Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new ...
Sanofi ships BEYFORTUS doses in the US to protect eligible babies against RSV, with a new FDA-approved filling line expanding manufacturing capacity. BEYFORTUS is the first long-acting monoclonal antibody for RSV prevention in newborns and infants up to 24 months.
Reference News
Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new ...
Sanofi ships BEYFORTUS doses in the US to protect eligible babies against RSV, with a new FDA-approved filling line expanding manufacturing capacity. BEYFORTUS is the first long-acting monoclonal antibody for RSV prevention in newborns and infants up to 24 months.